MindMaze Therapeutics Holding SA (V6M) Q2 2023 Earnings Report
DE:V6M Q2 2023 EPS Results
- Actual EPS
- -EUR 5.40
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 2.70
DE:V6M Q2 2023 Revenue Results
- Actual Revenue
- EUR 3.20M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -6.76%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 09/15/2023
- Time
- Before Open
- Conference Call
- Friday, September 15, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:V6M Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 27, 2026 | 2026 (Q2) | ―-0.05 | -0.38 | 87.39% (+0.33) | |
| Apr 09, 2026 | 2025 (Q4) | ―- | -1.06 | ― | |
| Aug 29, 2025 | 2025 (Q2) | ―-0.38 | -0.38 | 1.65% (+0.01) | |
| Apr 10, 2025 | 2024 (Q4) | ―-1.06 | -3.52 | 69.86% (+2.46) | |
| Aug 30, 2024 | 2024 (Q2) | ―-0.38 | -5.4 | 92.88% (+5.02) | |
| Mar 29, 2024 | 2023 (Q4) | ―- | ― | ― | |
| Sep 15, 2023 | 2023 (Q2) | ―-5.40 | -2.7 | -99.76% (-2.70) | |
| Mar 31, 2023 | 2022 (Q4) | ―-2.39 | -2.23 | -7.22% (-0.16) | |
| Sep 15, 2022 | 2022 (Q2) | ―-2.70 | -1.86 | -45.00% (-0.84) | |
| Mar 31, 2022 | 2021 (Q4) | ―-2.23 | -3 | 25.71% (+0.77) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
